In contrast, the tumor suppressive effects of ferroptosis were confirmed in another mouse glioma model using a therapeutic strategy that showed good penetration of the blood–brain barrier by a combination of Fe3O4 nanoparticles releasing Fe2+ and exosomal administration of small interfering RNA molecules suppressing the ferroptosis inhibitor, GPX4. This evidence concerns the gene GPX4 and glioma.